← Back to headlines
Eli Lilly CEO Discusses GLP-1s' Impact on America
The CEO of Eli Lilly and Company (LLY) shares insights on how GLP-1 medications are expected to reshape various aspects of America.
23 Jun, 19:55 — 23 Jun, 19:55
Sources
Showing 1 of 1 sources
Related Stories
Huawei and HP Sign Multi-Year Wi-Fi Patent Licensing Agreement
14m ago
Zoom and Intuit Project Strong FY2027 Revenue and EPS Growth
32m ago
Jack Ma and Alibaba Executives Buy $102 Million in Stock After Record Sale
39m ago
Honda Considers Halting New North American Plant Without Trade Deal Extension
43m ago